Back to search

Belgium· BE-AMP-SAM450186-00

Xigduo 5 mg - 1000 mg

A metformin and dapagliflozin product containing metformin hydrochloride, registered in Belgium by AstraZeneca. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD15

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedXigduo 5 mg - 1000 mgATCA10BD15REGISTER NO.BE-AMP-SAM450186-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Metformin and dapagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD15 (metformin and dapagliflozin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Metformin and dapagliflozin · ATC A10BD15

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Metformin Hydrochloride
Manufacturer
AstraZeneca
Country
Belgium (BE)
ATC code
A10BD15
ATC class
Metformin and dapagliflozin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    7717473
  • be_apb
    3123528
    EUR 47.7
  • be_apb
    3123585
    EUR 144.17

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for metformin and dapagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin and dapagliflozin · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and dapagliflozin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Diabetex, Glucophage
  • Bulgaria · Meglucon Xr, Metformin Interdos Pharma
  • Cyprus · Brotmin, Glucophage
  • Czechia · Brotmin, Glucomet
  • Germany · Glucophage, Juformin
  • Denmark · Forminet, Lyomet
  • Estonia · Brotmin, Diabufor Xr
  • Spain · Brotmin, Dianben
  • Finland · Forminet, Glucophage
  • France · Glimezit, Glucophage
  • United Kingdom (Northern Ireland) · Abiano, Axpinet
  • Greece · Glucoformin, Glucofree
  • Croatia · Aglurab, Belformin
  • Hungary · Adimet, Adimet Xr
  • Ireland · Glucophage, Metformin Accord
  • Iceland · Forminet, Glucophage
  • Italy · Glucophage, Glucophage Unidie
  • Lithuania · Brotmin, Metfogamma
  • Luxembourg · Glucophage, Metformax
  • Latvia · Brotmin, Glucient Sr
  • Malta · Brotmin, Glyformin
  • Netherlands · Glucient Sr, Glycofren
  • Norway · Forminet, Glucophage
  • Poland · Abmetfina Xr, Avamina
  • Portugal · Allmet, Glucophage
  • Romania · Brotmin, Glucophage
  • Sweden · Forminet, Glucophage
  • Slovenia · Aglurab, Glucophage
  • Slovakia · Glucophage, Glucophage Xr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5cceacb-62ea-49de-9d88-d9f887e96f0c
GET /v1/drugs/c5cceacb-62ea-49de-9d88-d9f887e96f0c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Xigduo 5 mg - 1000 mg",
  "name_fr": "Xigduo 5 mg - 1000 mg",
  "name_nl": "Xigduo 5 mg - 1000 mg",
  "amp_code": "SAM450186-00",
  "strengths": [
    "1000.0000",
    "5.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Metformin Hydrochloride",
    "Dapagliflozin Propanediol Monohydrate",
    "Dapagliflozin",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Metformin and Dapagliflozin",
  "authorisation_numbers": [
    "EU/1/13/900/008",
    "EU/1/13/900/007",
    "EU/1/13/900/010",
    "EU/1/13/900/009",
    "EU/1/13/900/012",
    "EU/1/13/900/011"
  ]
}

See everything about metformin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.